Related Experiment Videos
Therapeutic targets for osteoarthritis
1Stoke Mandeville Hospital, Rheumatology, Aylesbury HP218AL, UK. sally.Edmonds@buckshosp.nhs.uk
Maturitas
|May 9, 2009
Summary
Osteoarthritis (OA) is a complex condition affecting the entire musculoskeletal system. Current treatments focus on conservative management and lifestyle changes, as disease-modifying drugs are still under development.
Area of Science:
- Orthopedics and Rheumatology
- Gerontology
- Biomedical Engineering
Background:
- Osteoarthritis (OA) is a progressive, multifactorial musculoskeletal disease with increasing healthcare costs due to an aging population.
- Disease-modifying treatments for OA have lagged behind inflammatory arthropathies, suggesting current research directions may need re-evaluation.
- OA is increasingly recognized as a systemic condition impacting cartilage, bone, muscle, ligaments, and adipose tissue, necessitating a holistic approach.
Purpose of the Study:
- To review the current understanding of osteoarthritis (OA) as a complex musculoskeletal disease.
- To highlight the limitations in disease-modifying drug development for OA.
- To emphasize the importance of conservative management strategies and future research directions.
Main Methods:
- Literature review of osteoarthritis pathophysiology and treatment modalities.
- Analysis of current therapeutic approaches, including conservative management and emerging therapies.
- Discussion of the challenges in OA treatment and patient compliance.
Main Results:
- OA is a heterogeneous condition affecting the entire musculoskeletal system, not just cartilage.
- Effective conservative therapies include obesity management, exercise, and visco-supplementation.
- No disease-modifying therapy is currently available for OA treatment.
Conclusions:
- Future OA therapies should consider the biomechanics of the joint environment and the systemic nature of the disease.
- Improving patient compliance with existing conservative treatments is crucial.
- Further research is needed to develop effective disease-modifying treatments for osteoarthritis.
Related Concept Videos
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include: